Serum IL-37 Level Is Associated with Rheumatoid Arthritis and Disease Activity: A Meta-Analysis
Interleukin-37 (IL-37) inhibits the pathogenesis of rheumatoid arthritis (RA) via downregulating proinflammatory cytokines. Accordingly, we performed an analysis to accurately assess the relationship between serum IL-37 cytokine levels and disease activity of RA. Subgroup analysis and sensitivity an...
Main Authors: | Shengnan Cao, Haojun Shi, Guodong Sun, Yuanzhen Chen, Guangjian Hou, Dandan Wang, Bin Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/6653439 |
Similar Items
-
Association between Serum IL-37 and Spinal Cord Injury: A Prospective Observational Study
by: Yuanzhen Chen, et al.
Published: (2020-01-01) -
Correlation Between Level of Interleukin-37 and Rheumatoid Arthritis Progression
by: Zhu J, et al.
Published: (2021-05-01) -
Serum Levels of IL-22 and ACPA in Patients with Rheumatoid Arthritis
by: Zainab A. Aldhaher, et al.
Published: (2018-06-01) -
Expression level of serum Interleukin-37 in Rheumatoid Arthritis patients and its correlation with Disease Activity Score
by: Nimrah Akram, et al.
Published: (2018-08-01) -
Detection of IL-37 in peripheral blood of patients with rheumatoid arthritis and its clinical significance
by: Ge Zhang, et al.
Published: (2019-03-01)